Look at all the big deals involving starting pitching this offseason. Ricky Nolasco got four years, $49 million from the Minnesota Twins; Scott Feldman got three years, $30 million from the Houston Astros and Tim Hudson signed a two-year, $23 million deal with the San Francisco Giants.
Some of them may have gotten over their market value. For the New York Mets to get Bartolo Colon for two years at $20 million is a steal considering his 2013 season.
With the Oakland Athletics, Colon finished 18-6 with a 2.65 ERA and three shutouts. Colon had a BB/9 ratio of 1.4 and a K/9 ratio of 5.5. His statistics were off the charts as he produced one of the most underrated performances of the year. Colon looks good with the Mets, who are looking for a stop gap while Matt Harvey recovers from Tommy John surgery in 2014. Colon fits the role perfectly.
However, one wonders how much longer he can produce in the majors. He will be 41-years old by the time June rolls around, and it makes you wonder if his last two seasons were a fluke since he was out of baseball for two years and was suspended for PED use in 2012. However, given Colon’s season, he could have asked for more.
If Colon holds up, he could give the Mets 10-plus wins and if his ERA is around 3.00, he could help New York make some noise in the division or even make a run for the National League Wild Card. It will be difficult given the Mets’ rotation, but this move seems to be one of the smarter moves made by the front office in recent memory.